Henry Schein Inc

HSIC NASDAQ Healthcare & Biotech United States US8064071025
79.92 $
0.06 %

Henry Schein Inc is a global provider of health products and services, specializing in solutions for dental and medical health practitioners.

Performance & Momentum

6 Months 3.39 %
1 Year 11.10 %
3 Years 2.67 %
5 Years 6.53 %

Strategic Analysis

Henry Schein holds a specialized distributor position at the core of the supply chain for medical, dental, and veterinary practices. Its model combines the distribution of products, equipment, and services, enabling it to build recurring relationships with professional customers and to differentiate itself through the integration of value-added services rather than through hardware sales alone.

Strengths
  • Defensive positioning in essential niche markets, with relatively recurring demand
  • Diversified professional customer base across human and animal health, reducing dependence on any single segment
  • Ability to retain practitioners through an offering that combines distribution, equipment, and services
Weaknesses
  • Business exposed to structural margin pressure in distribution, with significant competition
  • Historically limited long-term stock value creation, reflecting a moderate growth and rerating profile
Momentum

Momentum appears decent but without any real acceleration, with an overall positive short-term trend that remains cautious given the historical performance record. The stock seems to be benefiting mainly from a stabilization dynamic rather than a clear reacceleration phase, making it more of a defensive quality name than a high-conviction stock on market momentum.

Similar stocks to Henry Schein Inc

Anantys Community

Be the first to share your analysis on Henry Schein Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases